Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome

被引：0
|
作者：
Creery, WD [1 ]
Hashmi, A [1 ]
Hutchison, JS [1 ]
Singh, RN [1 ]
机构：
[1] UNIV OTTAWA, DEPT PEDIAT, OTTAWA, ON K1N 6N5, CANADA
来源：
PEDIATRIC PULMONOLOGY | 1997年 / 24卷 / 05期
关键词：
acquired immunodeficiency syndrome; Pneumocystis carinii pneumonia; human immunodeficiency virus; acute respiratory distress syndrome; surfactant; infant;
D O I：
10.1002/(SICI)1099-0496(199711)24:5<370::AID-PPUL10>3.0.CO;2-6
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Pneumocystis carinii pneumonia (PCP) is an important cause of acute respiratory failure in HIV-infected children. PCP may initiate acute respiratory distress syndrome (ARDS) by adversely affecting surfactant physiology. We report improved pulmonary function following administration of bovine lipid extract surfactant to two infants with AIDS-related PCP/ARDS. (C) 1997 Wiley-Liss, Inc.
引用
下载
收藏
页码：370 / 373
页数：4
相关论文
共 50 条
  • [31] NONBRONCHOSCOPIC BRONCHOALVEOLAR LAVAGE FOR THE DIAGNOSIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    CAUGHEY, G
    WONG, H
    GAMSU, G
    GOLDEN, J
    CHEST, 1985, 88 (05) : 659 - 662
  • [32] MECHANICAL VENTILATION FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    FRANKLIN, CM
    FRIEDMAN, Y
    CHEST, 1994, 106 (02) : 643 - 643
  • [33] Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome
    Fisk, DT
    Meshnick, S
    Kazanjian, PH
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) : 70 - 78
  • [34] Gender differences in care for acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia
    Bastian, LA
    Sloane, RJ
    DeHovitz, JA
    Bennett, CL
    WOMENS HEALTH ISSUES, 1998, 8 (01) : 45 - 52
  • [35] Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: Who should receive prophylaxis?
    Sepkowitz, KA
    MAYO CLINIC PROCEEDINGS, 1996, 71 (01) : 102 - 103
  • [36] SPUTUM EXAMINATION FOR THE DIAGNOSIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    PITCHENIK, AE
    GANJEI, P
    TORRES, A
    EVANS, DA
    RUBIN, E
    BAIER, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (02): : 226 - 229
  • [37] TENSION PNEUMOMEDIASTINUM COMPLICATING PNEUMOCYSTIS-CARINII PNEUMONIA IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    RUMBAK, MJ
    WINERMURAM, HT
    BEALS, DH
    FRY, P
    CRITICAL CARE MEDICINE, 1992, 20 (10) : 1492 - 1494
  • [38] AEROSOLIZED PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    WEINBERG, A
    DANTONIO, SA
    DUARTE, MIS
    PEDREIRA, WL
    BARONE, AA
    ISHIOKA, S
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 1990, 32 (04): : 289 - 295
  • [39] DIFLUOROMETHYLORNITHINE FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    HINES, D
    BENSON, C
    SPEAR, J
    KESSLER, H
    ESHLER, B
    TRENHOLME, G
    CLINICAL RESEARCH, 1987, 35 (06): : A858 - A858
  • [40] DAPSONE-TRIMETHOPRIM FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    LEOUNG, GS
    MILLS, J
    HOPEWELL, PC
    HUGHES, W
    WOFSY, C
    ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) : 45 - 48
12345